
Siegfried to Buy Two Novartis Sites in Spain
Swiss CDMO Siegfried has signed a binding agreement with compatriot Novartis to acquire two pharmaceutical manufacturing sites in Spain. The Zofingen-based group said the buy will “significantly enhance” its global production network in terms of capacity and technological capabilities and will allow it to reach a critical size in finished dosage forms, thus creating further potential for profitable growth.







































